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Abstract
The consequence of numerous neurological disorders is the significant loss of neural cells,
which further results in multilevel dysfunction or severe functional deficits. The extracellular
matrix (ECM) is of tremendous importance for neural regeneration mediating ambivalent
functions: ECM serves as a growth-promoting substrate for neurons but, on the other hand,
is a major constituent of the inhibitory scar, which results from traumatic injuries of the central
nervous system. Therefore, cell and tissue replacement strategies on the basis of ECM mi-
metics are very promising therapeutic interventions. Numerous synthetic and natural materials
have proven effective both in vitro and in vivo. The closer a material’s physicochemical and
molecular properties are to the original extracellular matrix, the more promising its effective-
ness may be. Relevant factors that need to be taken into account when designing such materials
for neural repair relate to receptor-mediated cell–matrix interactions, which are dependent on
chemical and mechanical sensing. This chapter outlines important characteristics of natural
and synthetic ECM materials (scaffolds) and provides an overview of recent advances in de-
sign and application of ECMmaterials for neural regeneration, both in therapeutic applications
and in basic biological research.
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1 ECM MIMETICS ON THE RISE
The loss of nerve cells is a general and major symptom of many disorders of the ner-
vous system. After a traumatic injury, the differences in the regenerative response of
affected neurons of the peripheral nervous system (PNS) versus the central nervous
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system (CNS) become obvious:While neurons of the PNS reveal a significant degree
of regeneration after injury, such regenerative neuronal growth generally fails after
an injury of the adult CNS although central neurons have some, but very limited,
inherent regenerative capacity (David and Aguayo, 1981). The regenerative failure
after CNS trauma and neurodegeneration, therefore, cannot be attributed to just one
single cause, and the reasons for the difference in the regenerative responses of PNS
and CNS are manifold (Ferguson and Son, 2011) including (i) the presence of
myelin-associated inhibitors, (ii) a slower rate of degeneration of the distal segment
of the injured fiber tract, (iii) a generally slower axonal growth rate, and (iv) the in-
hibitory influences of the glial and the extracellular environment. Neurodegeneration
does, however, not only occur after CNS trauma. Neurodegenerative disorders like
Alzheimer’s disease, Parkinson’s disease, stroke, multiple sclerosis, and amyo-
trophic lateral sclerosis result in the shared symptom of neuroinflammation, which
eventually leads to the dysfunction or even the loss of neurons (Benowitz and
Popovich, 2011; Cartier et al., 2005). Because of a general significant increase of
the aging population and the consequence of an increased incidence of neurodegen-
erative diseases, the development of therapies, which may help to rescue and replace
the affected cells and thereby preserve the associated functions, is of highest priority.
The ECM is, therefore, an important target for the development of therapies for dis-
orders of the CNS, which involve progressive neurodegeneration. Such interventions
either directly target the inhibitory environment and its associated molecules, or they
function on the basis of replacement strategies. For the latter, ECMmimetics (natural
or synthetic matrix materials that mimic the characteristics of native ECMs) provide
promising means for cell- or matrix-based therapeutic treatments.
The previous chapters have described the neural ECM and its role in a variety of
healthy normal and injury-related processes in full detail. Chapters 16 and 17 discuss
current therapies that directly target the neural ECM. However, if such respective
therapies cannot be applied or are not efficient, e.g., in case of large tissue defects,
or if in vivo differentiation is intended after cellular transplantation, it may be nec-
essary to reconstruct the affected tissue. For example, via the application of suitable
matrix mimetics, a growth-promoting microenvironment can be created. This chap-
ter focuses on scaffold materials that are currently used as neural ECM mimetics in
basic research and experimental therapies (Figs. 1–3).
2 THE EXTRACELLULAR MATRIX
A brief outline of the natural ECM will illustrate its complexity and suggest the
difficulty and possible obstacles for the design of ECM mimetics: The ECM is com-
posed of a three-dimensional meshwork of fibrillar proteins and glycosaminoglycans
(GAGs) providing an interstitial matrix or basement membrane. The interstitial
matrix consists of polysaccharide gels and fibrillar proteins, whereas sheetlike de-
positions of ECM are characteristic for basement membranes. The molecular
ECM components are GAG-containing proteoglycans (chondroitin sulfate, heparan
sulfate, and keratin sulfate), nonproteoglycans containing polysaccharide hyaluronic
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FIGURE 1
Possible applications of neural ECMmimetics. Cell-based and a-cellular scaffolds are suitable
matrices for numerous strategies in both basic biomedical research and medical therapy.
FIGURE 2
Basic functions of the natural extracellular matrix. One important general feature, which is
exerted by the ECM, is the provision of a physically stable scaffold. The maintenance of ion
homeostasis and the exchange of nutrients are vital for the correct function of cellular
networks and tissues. ECM characteristics, which are especially important for cell–cell and
cell–matrix interactions, respectively, and which are mediated by a delicate ECM meshwork,
are highlighted by the light blue ellipse. These functions comprise the cellular processes of
differentiation, migration, adhesion, proliferation, and viability.
acid (HA), fibers of collagen or elastin, and connecting proteins such as fibronectin
or laminin. Due to their water-attracting features, proteoglycans keep the ECM well
hydrated. Furthermore, they aid in the entrapment and the storage of growth factors.
Collagens, the most abundant proteins of the ECM, are mostly fibrillary proteins that
provide structural and tensile support for cellular bonds. Exceptions are collagens
FIGURE 3
Requirements and considerations for the design of ideal neural extracellular matrix mimetics.
ThemorecloselyanECMmimetic resemblesthenaturalECM, thebetter it canexert thenecessary
functions. In addition to mechanical parameters, which strongly influence the cellular behavior
and tissuestability, general features (yellow (light gray inprint version)) ofanECMmimetic include
its biocompatibility, biodegradability, and its general composition. Many characteristics, which
are cell-specific (green (gray in print version)), would be considered for neural ECMdesign in cell
replacement and general cell implantation strategies, for example, the cell type, whereas other
basic functional requirements also apply for the general cellular behavior in a matrix (e.g.,
migration and differentiation). The different requirements certainly intermingle in an ideal neural
ECMmimeticand, therefore,shouldnotbeconsidered independently of eachother. For instance,
cell–cell interactions are very important cell-related functions, but they are also vital for the
structural organization, biocompatibility, etc. and for complex functions (blue (dark gray in print
version)) such as signaling or contact guidance. Finally, synthetic and natural ECM mimetics
canbedesignedand“tuned” toallowveryprecise functions (red(black inprint version)). This can
be achieved by the addition of bioactive groups to a scaffoldmaterial (surfacemodification) or by
incorporating different degrees of porosity. Thereby, vascularization and subsequently nutrient
exchange of an extracellular matrix can be influenced.
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of the nonfibrillary type including collagen IV, which forms the sheetlike meshed,
nonfibrillar network of the basement membrane. The important functions that are
common to ECMs in general are cell adhesion, cell communication, and cell differ-
entiation. ECMs provide structural stability to tissues. The formation of ECM is
essential for several vital processes, such as wound healing, growth, and fibrosis.
Cell–ECM interactions are highly dynamic bidirectional processes, which require
a very complex temporal and spatial coordination of signaling, receptor-mediated
transmission, and regulation of gene expression for their correct function. The three
main effectors in a native ECMmicroenvironment are insoluble hydrated macromol-
ecules, soluble macromolecules, and surface proteins of neighboring cells (Lutolf
and Hubbell, 2005). The molecular interaction of a cell with these effectors will de-
termine its ultimate fate, i.e., differentiation, proliferation, migration, apoptosis, or
other specific functions.
CNS trauma research models (e.g., experimental spinal cord injury) are useful in
order to explore the suitability of different materials as possible ECM mimetics
in vivo: large tissue defects that result from primary and secondary injury events
(e.g., inflammation, scarring, or cavity formation) and the pathological changes in
the native ECM require the removal and/or the reconstruction of the affected tissue
in order to restore tissue continuity. A variety of scaffold-based strategies exist in the
field of experimental CNS trauma, which involve either cellular transplantation or
the implantation of matrix materials as bridging substrates or a combination of both.
In vitro cell culture experiments often focus on the survival, migration, and differ-
entiation of the cells in a suitable matrix. In vivo cell transplantation approaches often
target similar effects, but the complex and mostly inhibitory environment requires
additional considerations.
3 INTERACTION OF ECM SCAFFOLD AND HOST ECM
The biocompatibility or the interaction of an artificial scaffold material with host tis-
sue can be modulated via the surface characteristics of the material. Different con-
ditions require different treatments and, therefore, different matrix characteristics.
While for cell replacement strategies the supply with factors that mediate cellular
differentiation, migration, and survival is of high priority, the degree of biodegrad-
ability is a very important issue in regenerative medicine because it can have a sig-
nificant effect on the extent of tissue regeneration. However, biodegradation of
implanted biomaterial can cause side effects on the surrounding host tissue
(Sakiyama-Elbert et al., 2012). Toxic by-products might elicit immune responses
or changes in the pH, which could weaken or even reverse any beneficial treatment
effects. Therefore, the efficiency of biomaterials that come into consideration as
ECMmimetics should ideally be investigated both in vitro and subsequently in vivo.
The most basic function of ECMs is the provision of a scaffold structure. For neu-
ral ECM mimetics, which are used as scaffold materials in regenerative medicine, it
is further desirable that they promote angiogenesis and vascularization. Blood ves-
sels are required for the provision of nutrients and removal of waste products,
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processes that are vital for tissue regeneration (Owen and Shoichet, 2010). Angio-
genesis and vascularization of the scaffold implant have been reported for numerous
neural ECM biomaterials (Bakshi et al., 2004; Bramfeldt et al., 2010; Estrada et al.,
2014; Plant et al., 1997; Woerly et al., 1999).
The presence and orientation of pores or channel structures in a matrix can guide
the cellular growth (Sakiyama-Elbert et al., 2012). Highly complex conditions like
spinal cord injuries require different molecular interventions or their combination to
mediate neural cell adhesion and axon sprouting and extension. Multiple cell types
and neuronal populations are affected by traumatic spinal cord injury, and therefore,
possible therapeutic strategies are numerous.
Often, cells will adhere nonspecifically to unmodified ECMs. Bioengineering
scaffold materials via incorporation of proteins or peptides on its surface can be used
to design scaffolds with specific cell–scaffold interactions to influence the cellular
behavior. Incorporation of specific peptide sequences, which promote cell adhesion,
is a common way of designing functionalized ECM mimetics with the potential for
enhanced cellular adhesion or better integration of the respective material (Choi
et al., 2013; Dhoot et al., 2004; Plant et al., 1997).
The physical structure and rate of degradation of a neural ECM scaffold have a
great impact on nervous tissue regeneration. If the material is degraded too fast, the
damaged tissue may lack the necessary mechanical support that is required for re-
generation. On the other hand, nondegradable materials provide a long-term struc-
tural stability but may be critical in regard to clinical applications since the implant
will remain in the patient’s body for an extended period of time or even permanently.
Optimal integration of ECM scaffold material will facilitate its effectiveness. It
is, therefore, a high priority to minimize scarring or allergic reactions caused by the
implanted material. Increased scarring responses can eventually result in an encap-
sulation of the foreign material from the adjacent host tissue (Sakiyama-Elbert et al.,
2012; Stensaas and Stensaas, 1978). With respect to cell–matrix interaction, the hy-
drophobic surface of a potential neural ECM scaffold material can significantly de-
crease the attachment of cells (Sakiyama-Elbert et al., 2012). This effect may be
desired for inflammatory cells or reactive astrocytes. But the overall prevention
of cellular adhesion is an unwanted effect, which would negatively influence neural
regeneration.
4 ECM MIMETICS
Recent advances in the design of materials, which imitate the microenvironment of
the ECM, include nanofibrillar networks, artificial ECM networks, and synthetic
polymers (Lutolf and Hubbell, 2005; Sadr et al., 2012; Tian et al., 2012; Tong
and Yang, 2014). Depending on their designated purpose, these scaffold materials
can be designed with different properties, regarding material type, ionic charge, gen-
eral physicochemical properties, incorporated bioactivity (functionalization), addi-
tion of soluble factors, or biodegradability.
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The guided cell growth that is provided by such materials is intended to facilitate
the structural and the functional reorganization and regeneration of dysfunctional tis-
sues. Therapeutic approaches, which make use of matrix- or scaffold-based strate-
gies, can be divided into two general classes (Lutolf and Hubbell, 2005):
1. Cell-based therapies
2. Acellular therapies
Cell-based therapies imply the delivery of cells and may involve the use of bioengi-
neered tissues (biohybrid scaffolds), whereas acellular therapies rather target cells of
the healthy residual tissues in situ, which can be stimulated and directed by the ma-
trix material in their growth or differentiation.
In the field of neurodegeneration, cell transplantation strategies are widely pur-
sued in basic research and therapy development. Although much progress has been
achieved in the respective research fields, to date, it is not possible to fully restore the
functions that have been lost or altered due to CNS trauma or neurodegenerative dis-
eases. The development of scaffold materials, which serve as a matrix for trans-
planted cells, has advanced quite rapidly in the last years. Application of such
ECM materials can promote the differentiation of stem cells into neurons and pro-
mote additional beneficial effects (Li et al., 2014; Ma et al., 2008; Preston and
Sherman, 2011). For cell survival and general cell behavior and function in ECM
scaffold-based cell cultures and cell transplantation approaches, it is vital to incor-
porate additional inducers into otherwise nonbioactive materials (Mammadov et al.,
2013). Ideally, for designing a suitable ECM mimetic, it is of great importance to
consider both the inhibitory environment, which can result from CNS trauma or in-
flammation (Fawcett, 2006; Fawcett and Asher, 1999; Fitch and Silver, 2008; Klapka
and Muller, 2006), and the different cues in the ECM, which significantly influence
the behavior of cells in their surroundings (Chen et al., 2013; Lock et al., 2008; Ulrich
et al., 2009). Such cues can be of different chemical, physical, or biological nature, or
they may be triggered by cellular interactions or soluble factors. The research of the
recent years has brought substantial knowledge regarding these interactions and their
underlying mechanisms (Burdick and Vunjak-Novakovic, 2009; Choi et al., 2010;
Engler et al., 2009; Kim et al., 2012). Therefore, the design of scaffold materials
can—at least in part—be tuned to a specific purpose.
For in vitro experiments, to induce neural differentiation, the addition of soluble
factors such as chemokines or growth factors to the culture medium is a common and
simple approach to mimic one aspect of the interaction of cells with the ECM
(Mammadov et al., 2013). The differing responses to various growth factors (neuro-
trophic factors, e.g., nerve growth factor (NGF), brain-derived neurotrophic factor
(BDNF), and neurotrophin-3 (NT-3)) have been described for many neuronal sub-
populations, and such information is advantageous for culturing the respective cells.
As a strategy to mimic the neural ECM, the supply of soluble factors alone has sev-
eral drawbacks, because it does not take into consideration the three-dimensional
network structure of the native ECM, which is important for cellular migration
and extension. Matrix materials that resemble the native ECM much more closely
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are three-dimensional scaffolding materials that can be modified further, e.g., via
combination with the abovementioned soluble factors. Martino et al. (2011) had
shown that the immobilization of growth factors on artificial scaffolds has a bene-
ficial effect for tissue regeneration.
A general advantage of hydrogel ECMmimetics is their ability to develop in situ.
This feature is especially useful when ECM scaffolds are required to bridge tissue
defects, which are often irregularly shaped (Estrada et al., 2014; Jain et al., 2006;
Sakiyama-Elbert et al., 2012). However, although hydrogels are considered as suit-
able ECM mimetic substrates whose porosity ensures the supply with nutrients,
growth factors, and oxygen to the cell, their porous nature is also disadvantageous.
Variation in stiffness causes changes in the porosity that might impair molecular dif-
fusion in the respective scaffold material. Three-dimensional materials can generally
provide the structural support, which is necessary for cellular interaction and proper
cellular function because it allows the biomolecular cell–matrix interaction.
When designing ECM mimetics, it is important to consider the multiple ECM
functions and the complex interaction between ECM components and cells. Model
ECMs can be naturally derived or they may be synthetic materials, and they can be
biodegradable or nondegradable. Materials from natural sources do have several ad-
vantages because of their inherent properties. Although, due to the generally high
degree of biocompatibility of natural ECM proteins, the application of these mate-
rials appears as a reasonable approach, the results of several recent studies, however,
suggest that such approaches may require additional interventions to lead to the de-
sired effects (Banerjee et al., 2009; Engler et al., 2006; Leipzig and Shoichet, 2009).
ECMmimetics are usually applied in vivo to support multicellular processes, e.g., the
formation and regeneration of tissues. Moreover, functionalization of the respective
material is often desired, e.g., the addition of bioactive groups such as self-
assembling peptides (Maude et al., 2013) or modifications enhancing biodegradabil-
ity (Liu et al., 2012).
Bioengineered ECM scaffolds can be designed for the controlled release of pro-
teins. In diffusion-based delivery systems, the amount of the released compound can
be regulated by physical characteristics, such as the pore size or the degree of poros-
ity, or by the degradation rate of the material (Houweling et al., 1998; Sakiyama-
Elbert et al., 2012). Drug delivery can also be achieved by affinity-based systems
(Taylor et al., 2006), which allow the controlled release of a substance. An additional
possibility is the covalent attachment of the compound to the material (Tian et al.,
2005). In this case, the release will occur solely via the degradation of the scaffold
material. Such manipulation by modulating physicochemical properties or adding
functionalized bioactive groups is a challenge, which is generally more successful
in synthetic materials rather than natural matrices.
Furthermore, purification, immunogenicity, and pathogen transmission are im-
portant issues that must be considered for ECM-based approaches, and regarding
such issues, the design of synthetic materials presents a well-controllable option.
Some of the most common natural and synthetic materials that have recently been
used as ECM mimetics are described below.
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5 BIOMEDICAL NEURAL ECM MIMETICS
5.1 NATURALLY DERIVED ECM MIMETICS
For many in vitro cell culture experiments, two-dimensional assays are still the
method of choice. However, the generally accepted opinion is that three-dimensional
matrices are the preferable ECM model systems because they mimic the physiolog-
ical situation of in vivo tissues more closely (Lutolf and Hubbell, 2005; Mammadov
et al., 2013; Owen and Shoichet, 2010). Examples for ECM models of natural
sources are matrices such as Matrigel™ (a basement membrane preparation derived
frommouse tumor tissue), matrices that consist of individual ECM components, such
as collagen, fibrin, or fibronectin, and fragmented or modified ECM components.
Natural ECMs are gels that consist of fibrous and fibrillary proteins within a hydrated
network of GAG chains. Their structural architecture and their inherent biophysical
properties can have significant effects on cellular functions, e.g., adhesion and mi-
gration. Naturally derived neural ECMmimetics have been used in therapeutic strat-
egies mostly either as cell carriers for tissue grafting or as regeneration-promoting
matrices that are implanted to bridge tissue defects.
5.1.1 Collagen
Collagen plays a dual role for neural growth and regeneration in vivo. It is the most
abundant protein of native ECMs, and its suitability as a growth-promoting scaf-
fold material has been studied extensively. Collagen’s inherent integrin binding
sites are advantageous as they promote the migration and differentiation of neu-
ronal cells (Bradshaw et al., 1995). Modification of collagen scaffolds via the ad-
dition of neurotrophic factors (Han et al., 2009; Houweling et al., 1998), other
pharmacologically active substances (Bolliet et al., 2008), or cells ( Joosten
et al., 2004) has been described to increase axonal regeneration and functional re-
covery after spinal cord trauma. Despite the fact that collagen per se is a suitable
substrate for neuronal growth, it is also important to consider the role of collagen
as the basement membrane constituent of the lesion scar that develops after a trau-
matic CNS injury (Fawcett et al., 2012; Klapka and Muller, 2006). The collagen
matrix of the lesion scar is a sticky matrix to which numerous growth-inhibitory
molecules that are upregulated after injury can adhere to and thereby impede neu-
ronal growth.
5.1.2 HA-Derived Materials
HA is a nonimmunogenic linear GAG that is a constitutive of soft connective tissue
and is involved in wound healing. It has been reported that HA implantation reduces
scar formation in both PNS and CNS (Wang et al., 2012). In this context, its inhib-
itory effect on the activation of astrocytes, CSPG deposition, and infiltration of mac-
rophages/microglia appears to be dependent on its molecular weight (Campo et al.,
2010; Khaing et al., 2011). A disadvantage of HA is that cells do not attach to its
surface (Wang et al., 2012). However, its combination with other scaffold materials
or functionalization with peptide sequences or other bioactive inducers has been
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described to result in suitable mechanical properties for CNS regeneration in vivo
(Wang and Spector, 2009) and promote neuronal differentiation in vitro
(Brannvall et al., 2007).
5.1.3 Alginate
Alginate is a water-soluble anionic polysaccharide distributed widely in the cell
walls of brown algae, where it forms a viscous gum through binding water. Alginate
is a linear copolymer with homopolymeric blocks of (1–4)-linked b-D-mannuronate
(M) and its C-5 epimer a-L-guluronate (G) residues, respectively, covalently linked
together in different sequences or blocks. Alginate is immunologically inert and is
not digested by mammalian cells. As the cross-linking multivalent cations gradually
diffuse out from the gel, it slowly degrades and is excreted in urine. Alginate gels are
frequently used as matrices for encapsulation of living cells and for the release of
proteins (Novikova et al., 2006; Tobias et al., 2001, 2005). In regeneration studies,
alginate gels are often applied as cell carrier substances. Alginate has been described
to enhance neuronal sprouting and to decrease inhibitory cues after CNS trauma
(Kataoka et al., 2004; Prang et al., 2006), but other studies have also reported a lack
of axon growth stimulation mediated by alginate scaffolds (Estrada et al., 2014;
Novikova et al., 2006). In vitro studies have even demonstrated that this biomaterial
can inhibit the growth of dorsal root ganglion neurons and cause alteration of the
phenotype of various different cell types (Novikova et al., 2006). This gel is, how-
ever, a quite suitable matrix for the encapsulation of cells with or even without
further modification of the material.
5.1.4 Agarose
The linear polysaccharide agarose is generally well tolerated after its implantation
(Tashiro et al., 1997). Although its mechanical properties can be modified to mimic
the mechanical properties of its host tissue (Balgude et al., 2001), an agarose ECMmi-
metic alone—when compared with the effectivity of other natural ECM mimetics—
does not suffice to achieve significant degrees of neuronal growth (Lin et al., 2005).
Viamodification of thematerial prior to implantation, the neuronal growth rate through
agarose scaffolds can, however, be increased (Gros et al., 2010; Jain et al., 2006; Lee
et al., 2010; Sakiyama-Elbert et al., 2012; Stokols and Tuszynski, 2006).
5.1.5 Matrigel™
Matrigel™ is a gelatinous ECM protein mixture obtained from the murine Engelbreth–
Holm–Swarm sarcoma. It comprises a mixture of Col4, laminin, and heparan sulfate
proteoglycan admixed with other minor amounts of extracellular components, as well
as growth factors. As a biodegradable implant, Matrigel™ resembles the complex ex-
tracellular environment found in many healthy tissues (Kleinman and Martin, 2005)
and is widely used as a substrate for cell culture, which forms a nonporous hydrogel
at physiological temperature. It has been described as a suitable matrix for tissue gen-
eration (Cassell et al., 2001) and has led to neuronal regeneration of varying degrees
from only limited growth to extensive axonal sprouting in several studies (Iannotti
400 CHAPTER 16 Neural ECM mimetics
et al., 2003; Novikova et al., 2006). Scaffolds of Matrigel™ allow only limited axonal
growth after spinal cord trauma (Estrada et al., 2014; Sakiyama-Elbert et al., 2012;
Someya et al., 2008). This ECM mimetic, however, seems to exert significant bene-
ficial, growth-promoting effects when it is used as a cell carrier medium in cell trans-
plantation studies. In combination with cellular transplants, especially Schwann cells,
Matrigel™ is a widely used biomaterial for neuronal regeneration, where it has been
shown to obtain positive results regarding axonal regeneration after central and periph-
eral nerve injury (Fouad et al., 2005; Novikova et al., 2006; Rodriguez et al., 2000;
Someya et al., 2008; Xu et al., 1995, 1997). In contrast to alginate, Matrigel™ has
not been found to alter the cellular morphology of olfactory ensheathing glia, Schwann
cells, or bone marrow stem cells, and it has been reported to stimulate the growth of
dorsal root ganglia in vitro (Novikova et al., 2006). Despite reported beneficial effects,
the clinical use of Matrigel™ remains questionable because of its tumor-derived origin
and its batch-to-batch variability (Sakiyama-Elbert et al., 2012). Batch variation,
which might significantly influence the effectiveness, is, in fact, a common disadvan-
tage of natural biomaterials when applied as ECM scaffolds (Orive et al., 2006; Owen
and Shoichet, 2010; Wang et al., 2012).
5.1.6 Chitosan
Thebiodegradable and nontoxic chitosan can bemodified to formscaffolds,which con-
tain pores or channels that facilitate neuronal growth (Li et al., 2009). Chitosan is pro-
duced via deacetylation of chitin. Themanipulation of chitosan and the resulting degree
of deacetylation have been reported to influence the adhesion andmigration behavior of
cells on the surfaceof thematrix (Chatelet et al., 2001).However, the growth-promoting
effects of chitosan scaffolds can be further enhanced via the introduction of functiona-
lized groups or combination with growth factors (Chen et al., 2011; Cheng et al., 2007;
Goraltchouk et al., 2006; Nomura et al., 2008; Yu et al., 2007).
5.1.7 Fibrin
The fibrous protein fibrin is involved in the clotting of blood during wound healing.
During this process of tissue repair, fibrin molecules form an ECMmeshwork, which
stimulates cellular proliferation and migration. Two RGD recognition sequences
provide binding sites for integrin receptors, which mediate cell adhesion and can sig-
nificantly influence cellular migration or growth processes (Mosesson, 2005). The
use of fibrin scaffolds is safe, lacking side effects. And manipulation of fibrin to cre-
ate delivery systems that can be used for controlled release of bioactive factors has
been tested extensively and yielded positive effects ( Johnson et al., 2010; Sakiyama-
Elbert et al., 2012; Taylor et al., 2006).
5.1.8 Fibronectin
Fibronectin is a key effector of fibrosis. As a globular plasma protein, it exhibits its
soluble form, and as an ECM protein, it takes on a fibrous insoluble form. Via its
binding to integrins through specific peptide sequences, it is strongly involved
in adhesion-mediated cellular migration (Iannotti et al., 2003). After CNS trauma,
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fibronectin ECM mimetics exert growth-promoting and guiding effects on spinal
axons (King et al., 2003; Phillips et al., 2004). Additionally, the promotion of cellular
infiltration of fibronectin scaffolds with regeneration-supporting glial cells has been
described (King et al., 2006).
5.2 SYNTHETIC ECM MIMETICS
Synthetic scaffold materials are generally developed with the intention to fabricate
matrices with structural characteristics that resemble those of the native ECM.
Although two-dimensional fibrous or fibrillary substrates may result in deviant cel-
lular shapes and behavior, they have proven quite successful in neural tissue engi-
neering approaches where they have been demonstrated to facilitate CNS
regeneration (Lutolf and Hubbell, 2005).
The design of synthetic ECMs offers several advantages: bioengineering technol-
ogies allow the fabrication of fibrillar biomaterials of nanometer-scale dimensions
via polymer processing or supramolecular self-assembly. The typical hydrogel char-
acter of native ECM can be physicochemically mimicked by synthetic hydrogels.
Synthetic hydrogels can often be formed in situ, which makes their application es-
pecially attractive for cell-containing hydrogels, which require gentle experimental
protocols (Lutolf and Hubbell, 2005).
The possibility to incorporate bioactive signaling cues in both fibrillary- and
hydrogel-based neural ECM renders them to be very useful scaffold materials for
tissue regeneration.
Both biodegradable and nondegradable synthetic matrices can be fabricated, and
their application has been investigated extensively.
5.2.1 Polyethylene Glycol
Polyethylene glycol (PEG) is a fusogen agent, which has been demonstrated to reunite
transected cell processes and seal cell membranes after mechanical spinal insult
(Borgens, 2001; Borgens and Bohnert, 2001; Borgens and Shi, 2000; Borgens et al.,
2002).AcutePEGtreatment after spinal cord traumahas alsobeen reported toexert neu-
roprotective effects via the reduction of oxidative stress reactions (Luo and Shi, 2004;
Luoet al., 2004).PEG isawidelyusedmaterial for thedesignofbiodegradable synthetic
cross-linkedhydrogels (Burdick et al., 2006;Conget al., 2009;Gunnet al., 2005;Herten
et al., 2009; Phelps et al., 2010; Qiao et al., 2005; Raeber et al., 2005; Rooney et al.,
2011). PEG has several beneficial features, which are advantageous for soft tissue re-
generation. PEG hydrogels are hydrophilic polymers that generally contain cross-links
that exert high degrees of swelling in aqueous environments such as soft tissues
(Hoffman, 2002; Lee and Mooney, 2001). PEG is biocompatible and PEG hydrogels
are generally not prone to nonspecific cell adhesion or protein adsorption. Such features
provide an ideal basis for the introduction of ECM-derived signals, which can stimulate
the regeneration of tissues and cells (Chung et al., 2008). Although PEG itself is a ma-
terial that cells generally do not attach to (Cong et al., 2009), bioengineered PEGhydro-
gels can also be used as a matrix for the delivery of cells.
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Although the most common approaches using PEG for ECM mimetics involve
the bioengineering of PEG-containing hydrogels, the generally inert, nontoxic,
and nonimmunogenic nature of PEG can also be made use of in a PEG polymer ma-
trix. Beneficial effects of a PEG biopolymer matrix have been described recently. In
the respective study, a solution of pure PEG 600 was applied after resection of spinal
scar tissue in rats with severe chronic spinal cord injury (Estrada et al., 2014). Al-
though PEG polymers per se do not conform to the basic requirement of an ECM
mimetic, which is to provide structural support, they nevertheless promote the for-
mation of a beneficial stable microenvironment in vivo. The PEG application pro-
moted the infiltration with cells, which are beneficial for the regeneration of
tissue in general and axons in particular. At the same time, the degree of reformation
of scar tissue was decreased, which allowed the development of a stable biomatrix at
the site of resection. Revascularization, invasion of astrocytes and Schwann cells,
and the formation of a stable ECM-containing biopolymer were reported. Further-
more, such PEG treatment alone was sufficient to result in the myelination of regen-
erated axons and significant locomotor functional improvements in the treated
animals (Estrada et al., 2014). Since the chemical properties of PEGs with different
molecular weights are nearly identical, the positive treatment effects in the latter
study were attributed to the physical properties of the applied PEG (PEG 600): while
the tested lower-molecular-weight PEG was too fluid to allow the material to remain
at the resection site, the tested PEG of a higher molecular weight even leads to an
encapsulation of the implanted material. Only PEG 600—a PEG with a low
viscosity—promoted the soft tissue regeneration in the treated area that resulted
in the observed cellular invasion and axonal elongation. Such findings argue for
the importance of the appropriate stiffness/viscosity that needs to be considered
for a respective application.
5.2.2 Lactide- and Glycolide-Derived Polyesters
Poly(lactic acid), poly(glycolic acid), and their copolymers poly(lactic-co-glycolic
acid) are widely used biomaterials for tissue engineering strategies. They are bio-
compatible and biodegradable, and their mechanophysical properties (and thus the
rate and timing of degradation) can be modulated to some degree (Sakiyama-
Elbert et al., 2012). However, several studies have reported undesired effects or a
lack of success that might be explained by the rate of degradation and a loss of struc-
tural support (Deumens et al., 2006; Hurtado et al., 2006).
5.2.3 Polycaprolactones
Polycaprolactones are biodegradable polymers, which can be used to fabricate three-
dimensional tubular structures with varying degrees of porosity. Implantation of
combinations of polycaprolactones with other polysaccharide-based hydrogel mate-
rials has been described to reduce inflammation responses after spinal cord injury
(Silva et al., 2010). Poly-e-caprolactone can be used for three-dimensional bioprint-
ing, which makes it a very promising material for novel personalized medical
approaches (Wong et al., 2008).
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5.2.4 Poly(2-hydroxyethyl Methacrylate)
Poly(2-hydroxyethyl methacrylate) is a nontoxic, nonbiodegradable hydrogel. The
material allows the attachment and growth of cells and the transport of small mole-
cules. It can also serve as a guidance substrate for neurons as has been shown for spinal
cord trauma (Hejcl et al., 2008). The nonbiodegradable nature can be considered as
both advantageous and unfavorable: It ensures the maintenance of a stable scaffold
structure over time. At the same time, especially in regard to its clinical application,
the scaffold will remain in the patient’s body after the implantation. As a foreign sub-
stance, it might cause side effects or unpredictable long-term consequences.
5.2.5 NeuroGel™
NeuroGel™ (N-(2-hydroxypropyl)methacrylamide or HPMA) is another nonbiode-
gradable hydrogel that has been described to support cellular infiltration, angiogen-
esis, and axonal growth after CNS trauma (Woerly, 2000; Woerly et al., 2001). The
surface of this scaffold can also be chemically modified via incorporation of bioac-
tive sequences to increase its beneficial effects.
5.2.6 Nanostructured Materials
Nanotechnology offers an enormous potential for the fabrication of nanostructures
(particles and fibers). Via electrospinning, nanofiber scaffolds that can be used
for cell culturing can be fabricated. Electrospun polyurethane scaffolds with high
porosity were previously shown to induce differentiation of hESCs into neurons
(Carlberg et al., 2009). In another study, PC12 cells seeded on NGF encapsulated
electrospun copolymer of e-caprolactone and ethyl ethylene phosphate scaffolds
were observed to exhibit enhanced neurite outgrowth (Chew et al., 2005). Chemical
conjugation to electrospun nanofibers is also effective in inducing neural differenti-
ation. NGF-conjugated aligned electrospun PEG-poly(e-caprolactone) nanofibers
induced transdifferentiation of MSCs into neural cells after 7 days (Cho et al., 2010).
5.2.7 Self-assembling Materials
Self-assembling nanofibers can be tuned in such a way that they form scaffold struc-
tures when injected into neural tissue (Berns et al., 2014). Self-assembling scaffolds
can be functionalized by using peptide sequences from ECM proteins or other neural
differentiation inducers that bind to cell surface receptors. Peptide amphiphiles that
self-assemble into nanofibers have successfully been used for neural differentiation
in vitro and for in vivo bridging of CNS tissue defects in several studies (Mammadov
et al., 2012a,b; Silva et al., 2004; Tysseling et al., 2010; Tysseling-Mattiace et al.,
2008). Self-assembled peptide nanofibers produced from alternating basic, hydro-
phobic, and acidic amino acids (RADA16) have also been shown to enhance neural
cell culture and provide therapeutic effects in several CNS dysfunctions (Ellis-
Behnke et al., 2006; Gelain et al., 2011; Guo et al., 2009; Holmes et al., 2000;
Silva, 2005). Composites of peptides and nanofibers are very promising scaffold ma-
terials for neural growth and regeneration. The incorporation of self-assembling
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nanofibers into other matrices makes them very suitable also for cell transplantation-
based approaches (Romano et al., 2011).
Generally, nerve grafts—the conventional but limited standard to treat neural
defects—have been replaced by the development of novel synthetic scaffolds.
The selected list of biomaterials described here covers only a portion of the numerous
potential ECM mimetic scaffolds. Recent advances in tissue engineering and nano-
technology demonstrate that neural replacement and repair can be achieved to a re-
markable extent. The intensive research regarding development and application of
neural ECM mimetics shows that a major determinant is the regulation of cellular
behavior by mimicking native ECM features. Desired material properties of neural
ECM are mechanical stability, biocompatibility with low or even absence of immu-
nogenicity, controlled biodegradability, and a structure that allows cell migration
(porosity) and vascularization. Current technological and engineering methods allow
highly specialized designs, which most likely will lead to rapid advances in regen-
erative medicine in the future.
6 LOST IN TRANSLATION
The replication of the native neural ECM environment is a major challenge. The quest
for suitable scaffoldmaterials has led to a better understanding of ECM-mediated func-
tions and has encouraged the development and optimization of suitable bioengineering
technologies. The ECMmimetic materials mentioned above only represent a selection
of the multitude of biomaterials, which can be used as neural ECM scaffolds.
A suitable ECM mimetic needs to exert the principal functions of the native ECM:
providing a structural scaffold and mediating cell proliferation, migration, differenti-
ation, survival, regeneration, angiogenesis, and invasion. The orchestration of these
cellular processes requires a functional network of biochemical and structural cues.
An important criterion for the design and application of a biomimetic ECM is
its translational potential. Regarding the translation from in vitro experiments to
the in vivo development of therapies in large animal models and into clinical
applications, it is necessary to prove the effectiveness of a material and its suitabil-
ity for the intended purpose both in vitro and in vivo. Moreover and very impor-
tantly, safety of the material needs to be demonstrated prior to its application
into patients.
Due to the number and complexity of physiological functions, which are medi-
ated by the native ECM, a single formulation cannot meet the requirements for ev-
ery task (Prestwich, 2008), from cell expansion and delivery to providing a stable
scaffold structure and from cell replacement strategies to large-scale repair of tissue
defects and regeneration-promoting therapies. For a translation from in vitro exper-
iments to clinical applications, it is, therefore, important to optimize the design of
ECM mimetic materials with high degrees of flexibility, which would allow the use
of few suitable materials for multiple purposes (Prestwich, 2008).
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